Evidence map›Paper›PMID 34128702›Full record

ArticlemBio2021

A CLK1-KKT2 Signaling Pathway Regulating Kinetochore Assembly in Trypanosoma brucei.

Manuel Saldivia, Adam J M Wollman, Juliana B T Carnielli, Nathaniel G Jones, Mark C Leake, Christopher Bower-Lepts, Srinivasa P S Rao, Jeremy C Mottram

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. CRISPR-Cas9 precision editing of kinetochore protein phosphosite codons inFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Manuel SaldiviaYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Adam J M WollmanYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Juliana B T CarnielliYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Nathaniel G JonesYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Mark C LeakeYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Christopher Bower-LeptsYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
Srinivasa P S RaoNovartis Institute for Tropical Diseases, Emeryville, California, USA.
Jeremy C MottramYork Biomedical Research Institute, Department of Biology, University of York, Heslington, United Kingdom.
University of York · GBNovartis (United States) · US

Funding

Wellcome Trust 103024Wellcome Trust 108517Wellcome Trust 200807Wellcome Trust 200807/Z/16/ZWellcome Trust 219639
6 · The paper itself

Abstract

During mitosis, eukaryotic cells must duplicate and separate their chromosomes in a precise and timely manner. The apparatus responsible for this is the kinetochore, which is a large protein structure that links chromosomal DNA and spindle microtubules to facilitate chromosome alignment and segregation. The proteins that comprise the kinetochore in the protozoan parasite Trypanosoma brucei are divergent from yeast and mammals and comprise an inner kinetochore complex composed of 24 distinct proteins (KKT1 to KKT23, KKT25) that include four protein kinases, CLK1 (KKT10), CLK2 (KKT19), KKT2, and KKT3. We recently reported the identification of a specific trypanocidal inhibitor of T. brucei CLK1, an amidobenzimidazole, AB1. We now show that chemical inhibition of CLK1 with AB1 impairs inner kinetochore recruitment and compromises cell cycle progression, leading to cell death. Here, we show that KKT2 is a substrate for CLK1 and identify phosphorylation of S508 by CLK1 to be essential for KKT2 function and for kinetochore assembly. Additionally, KKT2 protein kinase activity is required for parasite proliferation but not for assembly of the inner kinetochore complex. We also show that chemical inhibition of the aurora kinase AUK1 does not affect CLK1 phosphorylation of KKT2, indicating that AUK1 and CLK1 are in separate regulatory pathways. We propose that CLK1 is part of a divergent signaling cascade that controls kinetochore function via phosphorylation of the inner kinetochore protein kinase KKT2.

Indexed as

Gene Expression RegulationSignal TransductionKinetochoresMitosisPhosphorylationProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtozoan ProteinsTrypanosoma brucei bruceiClk dual-specificity kinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtozoan Proteinscell signalingkinetochoremitosisprotein kinasesTrypanosoma

Identifiers

PMID34128702
PMCPMC8262961
OpenAlexW3170771482

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.